Kylin Sees Potential for pRNA with Aptamers, But Keeps Its Eye on RNA Interference

Since the company's main focus remains developing pRNA for RNAi, the work with aptamers is being conducted primarily by academic collaborators.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories